Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Doxycycline | Case report

Skin infection by Mycobacterium farcinogenessenegalense group in an immunocompetent patient: a case report

Authors: An-Yu Cheng, Chih-Hung Lee

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Mycobacterium farcinogenessenegalense group mostly cause bovine farcy, which rarely infect human beings. We reported one case of cutaneous Mycobacterium farcinogenessenegalense group infection in an immunocompetent victim.

Case presentation

A 66-year-old Taiwanese woman with hypertension developed tender nodules on her left dorsal foot for 2 months. Tissue culture identified Mycobacterium farcinogenessenegalense group. The lesion was treated successfully with clarithromycin and sulfamethoxazole/trimethoprim, followed by surgical excision.

Conclusions

Mycobacterium farcinogenessenegalense group infection should be considered as a potential pathogen of skin infection in immunocompetent patients.
Literature
1.
go back to reference Hamid ME. Current perspectives on Mycobacterium farcinogenes and Mycobacterium senegalense, the causal agents of bovine farcy. Vet Med Int. 2014;2014:247906.CrossRef Hamid ME. Current perspectives on Mycobacterium farcinogenes and Mycobacterium senegalense, the causal agents of bovine farcy. Vet Med Int. 2014;2014:247906.CrossRef
2.
go back to reference Neuschlova M, Vladarova M, Kompanikova J, Sadlonova V, Novakova E. Identification of Mycobacterium species by MALDI-TOF mass spectrometry. Adv Exp Med Biol. 2017;1021:37–42.CrossRef Neuschlova M, Vladarova M, Kompanikova J, Sadlonova V, Novakova E. Identification of Mycobacterium species by MALDI-TOF mass spectrometry. Adv Exp Med Biol. 2017;1021:37–42.CrossRef
3.
go back to reference Rychert JA. Benefits and limitations of MALDI-TOF mass spectrometry for the identification of microorganisms. J Infectiol. 2019;2:1–5.CrossRef Rychert JA. Benefits and limitations of MALDI-TOF mass spectrometry for the identification of microorganisms. J Infectiol. 2019;2:1–5.CrossRef
4.
go back to reference Oh WS, Ko KS, Song JH, Lee MY, Ryu SY, Taek S, et al. Catheter-associated bacteremia by Mycobacterium senegalense in Korea. BMC Infect Dis. 2005;5:107.CrossRef Oh WS, Ko KS, Song JH, Lee MY, Ryu SY, Taek S, et al. Catheter-associated bacteremia by Mycobacterium senegalense in Korea. BMC Infect Dis. 2005;5:107.CrossRef
5.
go back to reference Wong TC, Chan WF, Tsang WL, Yeung SH, Ip FK. Mycobacterium farcinogenes infection after total hip arthroplasty. J Arthroplasty. 2005;20:684–7.CrossRef Wong TC, Chan WF, Tsang WL, Yeung SH, Ip FK. Mycobacterium farcinogenes infection after total hip arthroplasty. J Arthroplasty. 2005;20:684–7.CrossRef
6.
go back to reference Talavlikar R, Carson J, Meatherill B, Desai S, Sharma M, Shandro C, et al. Mycobacterium senegalense tissue infection in a child after fish tank exposure. Can J Infect Dis Med Microbiol. 2011;22:101–3.CrossRef Talavlikar R, Carson J, Meatherill B, Desai S, Sharma M, Shandro C, et al. Mycobacterium senegalense tissue infection in a child after fish tank exposure. Can J Infect Dis Med Microbiol. 2011;22:101–3.CrossRef
7.
go back to reference Maupin J, Cantrell A, Kupiec K, Melendez DP, Haleem AM. Mycobacterium senegalense osteomyelitis of the distal tibia: a case report. J Bone Joint Infect. 2019;4:140–5.CrossRef Maupin J, Cantrell A, Kupiec K, Melendez DP, Haleem AM. Mycobacterium senegalense osteomyelitis of the distal tibia: a case report. J Bone Joint Infect. 2019;4:140–5.CrossRef
8.
go back to reference Al Farsi F, Al Adawi B, Ba Tahir H, Al Mutani M, Adikaram C, Al Siyabi T, et al. Mycobacterium farcinogenes osteomyelitis of the proximal tibia: a case report. IDCases. 2021;25:e01194.CrossRef Al Farsi F, Al Adawi B, Ba Tahir H, Al Mutani M, Adikaram C, Al Siyabi T, et al. Mycobacterium farcinogenes osteomyelitis of the proximal tibia: a case report. IDCases. 2021;25:e01194.CrossRef
9.
go back to reference Kashihara E, Fujita K, Yamamoto H, Odagaki T. Mycobacterium farcinogenes infection after fracture repair of the tibia and fibula. IDCases. 2022;28:e01468.CrossRef Kashihara E, Fujita K, Yamamoto H, Odagaki T. Mycobacterium farcinogenes infection after fracture repair of the tibia and fibula. IDCases. 2022;28:e01468.CrossRef
Metadata
Title
Skin infection by Mycobacterium farcinogenes–senegalense group in an immunocompetent patient: a case report
Authors
An-Yu Cheng
Chih-Hung Lee
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07409-z

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.